Variables predicting clinical remission among adults with severe asthma treated with biologic agents
Selma Yeşilkaya, Kurtuluş Aksu, Gürgün Tuğçe Vural Solak, Özgür Akkale, Onur Telli, Hatice Çelik Tuğlu, Gözde Köycü Buhari, Sakine Nazik Bahçecioğlu, Sezgin Demir
Abstract
Background: Although biologic agents promise a short-to medium-term remission in asthma, it is unclear whether they can fundamentally alter disease course and achieve long-term remission. We aimed to investigate the clinical remission success of biologics in patients with severe asthma and the factors associated with remission.
Topics & Concepts
MedicineAsthmaMepolizumabInternal medicineUnivariate analysisLogistic regressionOmalizumabGastroenterologyPediatricsMultivariate analysisImmunoglobulin EImmunologyEosinophilAntibodyAsthma and respiratory diseasesRespiratory and Cough-Related ResearchIL-33, ST2, and ILC Pathways